1. Examining two approaches to U.S. drug pricing: international prices and therapeutic equivalency Publication: Washington, D.C. : Bipartisan Policy Center, October 2019 Subject(s): Costs and Cost AnalysisDrug CostsInsurance, Health, ReimbursementTherapeutic EquivalencyEuropeUnited States
